Bausch Health Beats Q3 Earnings and Revenue Estimates
AMPH Stock | USD 40.84 1.40 3.31% |
Under 55% of Amphastar's investor base is interested to short. The analysis of overall sentiment of trading Amphastar P stock suggests that many investors are impartial at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.
Amphastar |
Bausch delivered earnings and revenue surprises of 8.74 percent and 3.33, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
Amphastar Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amphastar can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amphastar Fundamental Analysis
We analyze Amphastar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Amphastar is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Amphastar P Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amphastar stock to make a market-neutral strategy. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics with similar companies.
Peers
Amphastar Related Equities
NBIX | Neurocrine Biosciences | 5.01 | ||||
COLL | Collegium Pharmaceutical | 2.09 | ||||
SUPN | Supernus Pharmaceuticals | 0.88 | ||||
ALKS | Alkermes Plc | 0.52 | ||||
PCRX | Pacira BioSciences, | 0.05 | ||||
PAHC | Phibro Animal | 0.13 | ||||
PBH | Prestige Brand | 0.38 | ||||
ANIP | ANI Pharmaceuticals | 0.41 | ||||
EOLS | Evolus | 0.60 | ||||
IRWD | Ironwood Pharmaceuticals | 0.84 | ||||
EVO | Evotec SE | 2.81 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |